Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Multicenter, Open-Labeled Study of Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma

NCT00042497 is registered in ClinicalTrials.gov with Anosys as lead sponsor.

NCT NCT00042497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00042497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Multicenter, Open-Labeled Study of Immunotherapy With Autologous Dexosomes for Patients With Stage IV Melanoma
Lead sponsor
Anosys
Phase
Phase 2
Overall status
Suspended
Start date
July 31, 2002
Completion date
Not reported
Enrollment
60
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma